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Background: In Western gender-neutral countries, the sex ratio at birth is estimated to be approximately 1.06. This
ratio is lower than the estimated sex ratio at fertilization which ranges from 1.07 to 1.70 depending on the figures
of sex ratio at birth and differential embryo/fetal mortality rates taken into account to perform these estimations.
Likewise, little is known about the sex ratio at implantation in natural and assisted-reproduction-treatment (ART)
cycles. In this bioessay, we aim to estimate the sex ratio at fertilization and implantation using data from embryos
generated by standard in-vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) in preimplantation genetic
diagnosis cycles. Thereafter, we compare sex ratios at implantation and birth in cleavage- and blastocyst-stage-transfer
cycles to propose molecular mechanisms accounting for differences in post-implantation male and female mortality
and thereby variations in sex ratios at birth in ART cycles.
Methods: A literature review based on publications up to December 2013 identified by PubMed database searches.
Results: Sex ratio at both fertilization and implantation is estimated to be between 1.29 and 1.50 in IVF cycles and 1.07
in ICSI cycles. Compared with the estimated sex ratio at implantation, sex ratio at birth is lower in IVF cycles (1.03 after
cleavage-stage transfer and 1.25 after blastocyst-stage transfer) but similar and close to unity in ICSI cycles (0.95 after
cleavage-stage transfer and 1.04 after blastocyst-stage transfer).
Conclusions: In-vitro-culture-induced precocious X-chromosome inactivation together with ICSI-induced decrease
in number of trophectoderm cells in female blastocysts may account for preferential female mortality at early
post-implantation stages and thereby variations in sex ratios at birth in ART cycles.
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In Western gender-neutral countries, the sex ratio at
birth is estimated to be ≈ 1.06 (for a review, see Hesketh
and Xing [1]). This ratio is lower than the estimated sex
ratio at fertilization which ranges from 1.07 to 1.70 de-
pending on the figures of sex ratio at birth and differen-
tial embryo/fetal mortality rates taken into account to
perform these estimations (for a review, see Pergament
et al. [2]). Likewise, little is known about the sex ratio
at implantation in natural and assisted-reproduction-
treatment (ART) cycles. Nonetheless, implantation is a
critical process that many embryos do not get through and,
therefore, this event should be considered as important as* Correspondence: tarinjj@uv.es
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through different stages of embryo/fetus development.
Fortunately, data from embryos generated by standard
in-vitro fertilization (IVF) or intracytoplasmic sperm
injection (ICSI) in preimplantation genetic diagnosis
(PGD) cycles may be used to estimate not only the sex
ratio at fertilization (primary sex ratio) in a more accur-
ate way than previous studies (for a review, see Perga-
ment et al. [2]) but also the still-unknown sex ratio at
implantation. In this bioessay, we use data from IVF and
ICSI embryos analyzed in PGD cycles as a proxy for
estimating the sex ratio at both fertilization and implant-
ation. Thereafter, we compare the sex ratios at implant-
ation and birth (secondary sex ratio) in cleavage- and
blastocyst-stage-transfer cycles to propose molecular mech-
anisms accounting for differences in post-implantationd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Table 2 Sex ratio (XY/XX) at birth of singleton deliveries
according to the method of fertilization applied and the






IVF ≤ Day 3b 0.98 (1929/1968) [23]
1.08 (2084/1932) [24]
Total: ≤ day 3b 1.03 (4013/3900)
> Day 3c 1.22 (1030/846) [23]
1.28 (1088/852) [24]
Total: > day 3c 1.25 (2118/1698)
ICSI ≤ Day 3b 0.94 (3047/3236) [23]
0.95 (2414/2542) [24]
Total: ≤ day 3b 0.95 (5461/5778)
> Day 3c 0.98 (1542/1566) [23]
1.10 (1289/1167) [24]
Total: > day 3c 1.04 (2831/2733)
aLarge-sample surveys using United States [23] and Australia and New Zealand
[24] assisted reproductive databases.
bCleavage-stage transfer.
cBlastocyst-stage transfer.
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Methods
A literature review based on publications up to Decem-
ber 2013 identified by PubMed database searches using
the following key words: sex ratio, preimplantation gen-
etic diagnosis, cleavage-stage transfer, blastocyst-stage
transfer, IVF, ICSI, biochemical pregnancy, fetal mortal-
ity, X-chromosome inactivation (XCI). This literature
search retrieved a limited number of studies and put in
evidence the absence of well-designed controlled ran-
domized trials analyzing the concomitant effect of both
insemination technique (IVF versus ICSI) and develop-
mental stage at the time of embryo biopsy/transfer
(cleavage versus blastocyst stage) on sex ratio of em-
bryos/newborns. Notably, only one article [3] compiling
the chromosomal sex of 117 IVF 4- to 8-cell embryos
from PGD cycles was identified in our literature search.
This is not surprising because during the early nineties,
before the advent of ICSI, PGD technology was in its in-
fancy, and patients and PGD laboratories were limited.
For instance, the article by Griffin et al. [3] is a compen-
dium of 27 PGD cycles performed in 4 separated series
at the Hammersmith Hospital, London, over a 2-year
period in 18 couples at risk of transmitting X-linked
recessive disorders. Oocytes and embryos were cultured
in Earle’s Balanced Salt Solution (EBSS) supplemented
with 10% heat-inactivated maternal serum and biopsied
blastomeres analyzed by fluorescent in situ hybridization
(FISH). Consequently, estimates of sex ratios at fertili-
zation and implantation based on data shown in Table 1
should be considered as relative values, not as absolute
and precise figures. Estimates of sex ratios at birth from
Table 2 are based on larger sample sizes and therefore are
more robust than estimates of sex ratios at fertilizationTable 1 Sex ratio (XY/XX) of genetically diagnosed
preimplantation embryos according to the method of








IVF 1.50b (60/40) [3]
Total: 1.50b (60/40)




Total: 1.09 (960/881) Total: 0.98 (225/229)
aIn the IVF group, a total of 25 (17 males and 8 females) and 75 (43 males and
32 females) embryos were analyzed at the 4- and 8-cell stage, respectively.
In the ICSI group, all the embryos were analyzed at the 8-cell stage.
bSex ratio of 4- to 8-cell embryos would be 1.29 (66/51) if we consider 17 extra
embryos that exhibited abnormal number of X and Y signals in the
biopsied cell(s).and implantation in IVF cycles. In any case, comparisons
between groups in this bioessay should be performed in a
qualitative way, not in a quantitative/statistical mode using
meta-analysis or statistical inference methods.
Fertilization and preimplantation stages
It has been reported that human ejaculated spermatozoa
display a normal Y:X ratio that does not differ from the
Mendelian ratio [4-6]. Nevertheless, Table 1 shows that
genetically diagnosed 4- to 8-cell IVF embryos exhibit
sex ratios between 1.29 and 1.50. These figures contrast
with the sex ratio closer to unity displayed by ICSI 8-cell
embryos (1.09). Differences in sex ratios between IVF
and ICSI embryos may be due to the fact that ICSI by-
passes the zona pellucida and thereby any putative role
it may have in selecting X- or Y-bearing spermatozoa
(see below). Nevertheless, we should note that the sex ra-
tio of cleavage-stage ICSI embryos is biased towards fe-
males when performing sperm selection for normal
shaped nuclei, especially under high magnification (0.53,
112/210, in selected sperm injection versus 0.86, 96/112,
in standard ICSI) [7] or when using the swim-up tech-
nique for preparation of spermatozoa from heavy smokers
(0.47, 22/47, in heavy smokers; 0.95, 21/22, in slight-to-
moderate smokers; and 1.13, 80/71, in non-smokers) [4].
There are several mechanisms that may account for
the relatively elevated sex ratio found in IVF 4- to 8-cell
embryos: (i) IVF male embryos may have a developmental
advantage over female embryos after fertilization; (ii) the
sperm preparation technique (either swim-up or three-
layer discontinuous Percoll density gradient centrifuga-
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Y-bearing spermatozoa; (iii) the molecular composition
of the zona pellucida may render oocytes more susceptible
to fertilization by Y-bearing spermatozoa; and/or (iv)
Y-bearing spermatozoa may have higher fertilization ability.
Previous studies have reported that the sex ratio of
preimplantation bovine embryos may be skewed towards
males (i.e., preferential loss of female embryos) by ma-
nipulating the culture system including addition of glu-
cose [8,9] and glucosamine [10]. In contrast, in humans
the possibility that IVF male embryos have a develop-
mental advantage over female embryos after fertilization
is not supported by data on preimplantation embryo de-
velopment. Firstly, it is known that ≈ 10% of all human
IVF (or ICSI) embryos undergo early developmental ar-
rest [11]. This arrest likely occurs to prevent further de-
velopment of certain chromosomally abnormal embryos
and/or embryos that fail to activate embryonic genome
around the 4- to 8-cell stage [12]. Of note, this early de-
velopmental block does not seem to depend on sex of
embryos. Actually, a non-significant sex ratio of 1.05
(86/82) has been evidenced in arrested embryos that do
not pass the 8-cell stage after IVF [13]. And secondly, as
shown in Table 1, the sex ratio of both ICSI 8-cell em-
bryos (1.09) and day-5 blastocysts (0.98) is close to unity
suggesting that further developmental arrest after the
8-cell stage is not sex dependent. Indeed, the develop-
mental potential of ICSI 8-cell embryos towards the
early, full or hatched-blastocyst stage on day 5 is similar
between male (23.1%, 110/475) and female (21.6%, 88/
408) embryos [14]. Consequently, we can assume that
the sex ratio at both fertilization and implantation is be-
tween 1.29 and 1.50 in IVF cycles (the sex ratio of
cleavage-stage embryos) and 1.07, 1185/1110, in ICSI cy-
cles (this estimate results from combining sex ratios of
cleavage-stage and blastocyst-stage ICSI embryos; see
Table 1). We should note that the estimates of sex ratios
at fertilization and implantation in IVF cycles are not ro-
bust due to the relative small number of embryos ana-
lyzed (n = 117) and the bias that may be introduced by
inferring sex ratios at fertilization and implantation from
data of cleavage-stage embryos. We should bear in mind
the work by Fiala [15] pointing out that the sex ratio of
surviving offspring cannot correctly be used to estimate
the primary sex ratio because of the potential sex differ-
ential of mortality. Unfortunately, obvious ethical rea-
sons prevent assessing directly sex ratios at fertilization
and implantation in human beings.
The second option, i.e., the sperm preparation tech-
nique used in IVF may increase the proportion of
Y-bearing spermatozoa, can be also rejected. In fact, it
has been shown that the swim-up technique does not se-
lectively enrich either X- or Y-bearing spermatozoa
[16-18]. As mentioned above, only in heavy smokingmen swim-up technique may increase the proportion of
X-bearing (instead of Y-bearing) spermatozoa resulting
in higher incidence of female embryos after ICSI [4].
Moreover, it is known that the three-layer discontinuous
Percoll density gradient selects spermatozoa with better
motion characteristics, more hyperactivation, and im-
proved longevity compared with direct swim-up [19].
However, studies aimed to ascertain the efficiency of
discontinuous Percoll density gradient centrifugation in
sperm sorting show either no significant effect on X:Y ra-
tio of spermatozoa or even an enrichment of X-bearing
spermatozoa that seems to be insufficient for clinical use
in pre-conceptional sex selection (for references, see
Lin et al. [20]).
The third and fourth possibilities, i.e., oocytes may be
more susceptible to fertilization by Y-bearing spermato-
zoa and/or Y-bearing spermatozoa may have higher
fertilization ability, are more likely to be true. Indeed, re-
cent evidence strongly suggests that oocytes during a
critical time in folliculogenesis may change the molecu-
lar composition of the zona pellucida, e.g., a subtle
variation in a sperm-binding carbohydrate on the zona-
pellucida proteins induced by high levels of follicular-
fluid testosterone. This molecular change may render
oocytes more susceptible to fertilization by Y-bearing
spermatozoa (for a review, see Grant and Chamley [21]).
In addition, there are convincing data on the presence of
distorter genes, expressed and translated after meiosis in
round spermatids and spermatozoa, able to skew the sex
ratio by affecting spermatid maturation and fertilizing
ability of either X- or Y-bearing spermatozoa (for a re-
view, see Ellis et al. [22]). This fact suggests that human
spermatids and spermatozoa may “intrinsically” express
distorter genes favoring spermatid maturation and fertil-
izing ability of Y-bearing spermatozoa.
Implantation and early post-implantation stages before
pregnancy becomes clinically recognized
Table 2 shows data retrieved from United States [23]
and Australia and New Zealand [24] assisted reproduct-
ive databases. We selected these studies because they fo-
cused their analyses on large samples of ART singleton
deliveries [23] or births resulting from single embryo
transfers [24]. Noteworthy, Dean et al. [24] included in
the calculation and analysis of sex ratio at birth only one
baby from each set of multiple births. This strategy elim-
inated the potential bias that monozygotic twins may
introduce in the calculation of sex ratio at birth. These
data indicate that extended embryo culture to the blasto-
cyst stage is associated with higher sex ratio at birth
compared with shorter embryo culture to the 4- or
8-cell stage (1.25 versus 1.03 in IVF cycles and 1.04 ver-
sus 0.95 in ICSI cycles). Moreover, sex ratio at birth is
lower in ICSI cycles than in IVF cycles after cleavage-
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transfer. These results are qualitatively consistent with a
previous systematic review and meta-analysis [25] and
previous studies [26-29] not included in Table 2 because
they did not provide the appropriate information and/or
did not control for the potential bias associated with
monozygotic twining.
The higher sex ratio at birth evidenced after blastocyst-
stage transfer is not likely a consequence of embryo grad-
ing systems that prioritize male embryos for transfer as
suggested by Alfarawati et al. [30]. Indeed, despite an early
study [31] reported that male IVF human preimplantation
embryos display increased number of cells and metabolic
activity than female embryos, strong evidence shows that
human preimplantation male embryos do not cleave faster
[32-34], exhibit better morphology [32] and/or have higher
developmental potential [13,14] than female embryos.
This fact suggests that the human endometrium does not
select the sex of implanting embryos as previously hypoth-
esized by Krackow [35] and Tarín et al. [36], or evidenced
in mouse embryos displaying sex-dimorphic developmen-
tal rates [37,38]. Instead, we propose that the higher
secondary sex ratio found after blastocyst-stage transfer
may be due to preferential female mortality at early post-
implantation stages induced, at least in part, by abnormal
inactivation of one of the two X-chromosomes (mechan-
ism of dosage compensation).
XCI in the mouse model
Two recent reviews by Lee and Bartolomei [39] and
Lessing et al. [40] show that in the mouse XCI begins
during the first meiotic prophase of spermatogenesis.
After completion of meiosis, the X-chromosome does
not completely reactivate. Indeed, 85% of X-linked genes
remain suppressed through spermiogenesis. Thus, the
paternal X-chromosome is passed onto the next gener-
ation in a partially inactivated state. At the 2-cell stage,
transcription of repetitive elements on the paternal
X-chromosome is already suppressed, but transcription
of X-linked coding genes is active. At the 8-16-cell stage
(morula stage), the silencing of paternal coding genes is
initiated, and is completed at the blastocyst stage or
later. Gene silencing absolutely requires cis accumula-
tion of a long non-coding Xist RNA that coats the
X-chromosome and binds Polycomb repressive complex 2
(PRC2), the epigenetic complex responsible for trimethyla-
tion of histone H3 on lysine 27 (H3K27me3), a repressive
epigenetic mark that leads to further silencing of the pa-
ternal X-chromosome. This is not the case for silencing
repetitive elements on the paternal X-chromosome. By the
2-cell stage, although Xist RNA is present, repetitive ele-
ments are silenced in a Xist independent manner. The ma-
ternal X-chromosome is protected from inactivation
through expression of Xist’s antisense repressor,Tsix.As paternal XCI is heritable through mitosis, the pa-
ternal X-chromosome remains inactivated in both the
trophectoderm and the primitive endoderm (hypoblast).
In contrast, in the inner cell mass (ICM), the paternal
X-chromosome undergoes reactivation. We should bear
in mind that the trophectoderm gives rise to the fetal
portion of the placenta; the primitive endoderm origi-
nates the parietal endoderm that contributes to the
parietal yolk sac, and the visceral endoderm that con-
tributes to the visceral and intraplacental yolk sacs; and
the ICM gives rise to the epiblast lineage that develops
into the embryo proper and the extra-embryonic meso-
derm that forms the allantois and the mesodermal com-
ponents of the visceral yolk sac, amnion and chorion
(for reviews, see Hemberger [41] and Gasperowicz and
Natale [42]).
Starting from the period shortly after implantation,
X-chromosomes in the epiblast experience random in-
activation, i.e., the maternal X-chromosome is inactive
in some cells whereas the paternal X-chromosome is in-
active in other cells. Paternal X-chromosome reactiva-
tion also occurs in primordial germ cells in preparation
for equal segregation during meiosis (for reviews, see
Lee and Bartolomei [39] and Lessing et al. [40]).
XCI in humans
Unlike in mice, XIST expression is not imprinted in
humans. XIST expression is detected from the 4- to
8-cell stage at the onset of genomic activation [43]. Both
ICM and trophectoderm show similar XIST RNA
accumulation in their cells. However, XIST upregulation
does not result in immediate onset of chromosome-wide
XCI even in late (day-7) blastocysts [44]. Recently,
Teklenburg et al. [45] using an in-vitro model for human
implantation observed that implanting day-8 female em-
bryos had distinct H3K27me3 foci (presumably on the
inactive X-chromosome) localized to the trophectoderm
lineages and to lesser extend the hypoblast lineages, but
not in epiblast cells. These findings indicate that in the
majority of the cells of human embryos, silencing of the
X-chromosome may occur after the embryo has im-
planted. This conclusion contradicts data from another
study reporting that XIST RNA accumulation is associ-
ated with transcriptional silencing of the XIST-coated
chromosomal region as early as the morula and the
blastocyst stage [43]. Discrepancies between studies may
be explained by differences in efficiency of the immuno-
fluorescence/FISH technique in detecting biallelic RNA
signals and/or the use of different culture conditions
(cited by Okamoto et al. [44]).
Early studies suggested the occurrence of paternal XCI
in the fetal side of placentae. These studies analyzed the
expression pattern of single X-linked genes. However,
other studies using more robust analyses of multiple
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support the notion that XCI in human placentae is ran-
dom (for a review, see Lee and Bartolomei [39]). Simi-
larly, it is generally accepted that X-chromosomes in
the ICM lineage undergo random inactivation (for a re-
view, see Migeon [46]). Notwithstanding, a recent study
has shown that the bell-shaped distribution (centered
around 50%) of X-inactivation patterns in large popula-
tions of normal women fits better a three-allele model of
genetically influenced XCI than models of completely
random inactivation [47].
We should emphasize that not all the X-linked genes
are silenced at X-inactivation. In humans, more than
15% of genes carried on the X-chromosome appear to
escape inactivation (for a review, see Brown and Greally
[48]). Consequently, differences in gene dosage may
explain differences between men and women in develop-
mental programming and disease susceptibility and
behavior (for a review, see Aiken and Ozanne [49]).
Moreover, although XCI in human epiblast, hypoblast
and trophectoderm cells likely occurs during/after im-
plantation (see above), the silencing process may be dis-
rupted during preimplantation stages by any factor that
interferes with DNA methylation, histone deacetylation
or chromatin modifications. The resulting increased or
decreased X-linked gene expression may prevent embryos
to either implant or develop normally after implantation
(for reviews, see Hemberger [50] and Schulz and Heard
[51]). We propose that extended exposure of preimplanta-
tion female embryos to suboptimal (non-physiological)
culture systems may be “one” of these factors.
Precocious XCI in human embryonic stem cells (hESCs)
It has been reported [52] that the conventional method
of hESCs (pluripotent cell types derived from the ICM
of human blastocysts) derivation and maintenance under
atmospheric O2 conditions (≈20% O2) as well as expos-
ure to other cellular stresses such as harsh freeze-thaw
cycles, inhibition of the proteosome, HSP90, gamma-
glutamylcysteine synthetase, and treatment with organic
peroxide, induces precocious random XCI prior to cellu-
lar differentiation. This precocious XCI is associated
with either XIST expression in most or all cells, or the
absence of XIST expression and failure to reactive XIST
expression upon differentiation. This response differs
from that found under 5% O2 concentration. In this
case, the precocious random XCI in hESCs is prevented,
being both X-chromosomes active. Furthermore, hESCs
exhibit no XIST expression and retain the ability to acti-
vate XIST gene expression upon differentiation.
It is worth mentioning that nowadays in many IVF la-
boratories gametes and embryos are still exposed to
non-physiological culture systems including atmospheric
O2 concentrations despite data from a systematic reviewand meta-analysis [53] suggest that embryo culture to
the blastocyst stage under low-oxygen concentration
(≈5%) versus high-oxygen atmospheric concentration
yields higher live birth rates. Thus, it can be inferred that
embryos cultured to the blastocyst stage (embryo transfer
on day 5 or 6) under non-physiological environments
including atmospheric O2 concentrations are more sus-
ceptible to undergo epigenetic changes than embryos
cultured for shorter periods of time (embryo transfer on ≤
day 3). Like hESCs, these epigenetic changes may interfere
with the normal process of XIST expression and XCI in
female embryos. Importantly, in-vitro-produced preim-
plantation bovine embryos display higher levels of XIST
expression than their in-vivo counterparts, suggesting that
in-vitro-culture conditions induce premature XCI [54].
We should stress that in the subgroup of hESC lines
displaying precocious XCI and XIST expression in most
or all cells when exposed to atmospheric O2 conditions
[52], XIST expression was unstable and subject to stable
epigenetic silencing by DNA methylation. The resulting
inhibition of XIST expression reactivated a portion of
X-linked alleles on the inactive X-chromosome (12% of
X-linked promoter CpG islands became hypomethylated)
[55]. Such a reactivation resulted in over-expression of
X-linked genes, event that if took place in implanting fe-
male blastocysts may produce severe abnormalities
in embryonic and extra-embryonic (trophoblast) tissues
and early embryonic death (for a review, see Schulz and
Heard [51]).
Data supporting and refuting the hypothesis of occurrence
of precocious XCI in human female embryos
The hypothesis of occurrence of precocious XCI in fe-
male embryos exposed for extended periods of time to
non-physiological culture systems is questioned by (i)
the absence of significant differences in miscarriage per-
centage per couple after cleavage- (8.0%, 86/1069) and
blastocyst-stage (9.2%, 97/1058) transfer; and (ii) the
higher live-birth percentage per couple after blastocyst-
stage transfer (38.9%, 292/751, versus 31.2%, 237/759,
after cleavage-stage transfer) (for a systematic review
and meta-analysis, see Glujovsky et al. [56]). As a matter
of fact, we should expect higher miscarriage percentages
and lower live-birth percentages after blastocyst-stage
transfer if a given percentage of female embryos under-
goes precocious XCI. However, it is generally thought
that extended culture selects those embryos that have
proven ability to survive and develop to an advanced
stage in vitro [although a wide range of blastulation rates
has been reported (from 28% to 97%), on average only
46.8% of embryos reach the blastocyst stage (for a sys-
tematic review and meta-analysis, see Glujovsky et al.
[56])]. This fact together with the presence of an uterine
environment that likely is more synchronized compared
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Bourgain and Devroey [58]) may contribute to the simi-
lar miscarriage rates and higher live-birth percentages
reported after blastocyst-stage transfer compared with
cleavage-stage transfer.
In addition, the incidence of female losses (presumably
caused by precocious XCI) is likely higher at early stages
of pregnancy before women are aware that they are
pregnant than after pregnancy has been clinically recog-
nized (note that early pregnancy losses are not taken
into account when analyzing miscarriage percentages).
In this context, we should mention that blastocyst-stage
transfer is associated with higher percentage of bio-
chemical pregnancy losses per embryo transfer (14.1%,
108/767) [59] than cleavage-stage transfer (8.2%, 154/
1888) [60].
Late post-implantation stages after pregnancy becomes
clinically recognized
Shortly after pregnancy becomes clinically recognized,
females keep displaying a developmental disadvantage
compared with males. This disadvantage subsequently
vanishes as gestational age increases. In particular, by
combining the data reported by Eiben et al. [61] and
Yusuf and Naeem [62], sex ratios of chromosomally nor-
mal abortions increase from 0.46, 67/147, at 5–9 weeks
of pregnancy to 0.79, 137/173, at 10–13 weeks and 1.02,
269/263, at ≥ 13 weeks. A concomitant increase in nat-
ural selection against males with gestational age is also
evidenced in chorionic villus sampling and amniocen-
tesis material from control pregnant women. In these
ongoing pregnancies, sex ratios significantly decrease
from 1.28, 791/618, at < 16 weeks of pregnancy to 1.06,
25433/23994, at ≥ 16 weeks [63]. We should bear in
mind that human males and females develop at different
rates in uterus (and postnatally until the postpubertal
stage). Thus, male fetuses have a greater effective expos-
ure to a given insult than female fetuses that undergo
fewer cell cycles during the same period of exposure
(for a review, see Aiken and Ozanne [49]).
Birth
Table 2 shows that, compared with the estimated sex ra-
tio at implantation (1.29 to 1.50 in IVF cycles and 1.07
in ICSI cycles), the sex ratio at birth is lower in IVF cy-
cles (1.03 and 1.25 after cleavage- and blastocyst-stage
transfer, respectively) but similar and closer to unity in
ICSI cycles (0.95 and 1.04 after cleavage- and blastocyst-
stage transfer, respectively). Note that we should expect
lower sex ratios at birth than at implantation if male
mortality during pregnancy surpasses female losses. On
the contrary, we should expect sex ratios at birth similar
to or even higher than sex ratios at implantation if fe-
male mortality is comparable or exceeds male mortality.We should stress that sex ratios at birth are closer to
sex ratios at implantation after blastocyst-stage-transfer
than after cleavage-stage-transfer. This fact is in conson-
ance with the hypothesis of occurrence of precocious
XCI in female embryos cultured in vitro to the blastocyst
stage. Likewise, sex ratios at birth are nearer to sex ratios
at implantation in ICSI than in IVF cycles. In this con-
text, we should mention the study by Dumoulin et al. [64]
reporting decreased number of trophectoderm cells in
ICSI female blastocysts compared with ICSI male blasto-
cysts (this effect was not observed in IVF blastocysts). As
the trophectoderm lineage gives rise to the fetal portion of
the placenta, ICSI female blastocysts may exhibit higher
incidence of abnormal trophoblast function and decreased
potential for implantation and further development com-
pared with ICSI male blastocysts.
Concluding remarks
Data from genetically diagnosed preimplantation em-
bryos suggest that the sex ratio at both fertilization and
implantation is between 1.29 and 1.50 in IVF cycles and
1.07 in ICSI cycles. Embryo exposure to culture media
for extended periods of time to the blastocyst stage
under non-physiological conditions (e.g., under atmos-
pheric O2 conditions) may induce precocious XCI in fe-
male embryos. Such a precocious XCI together with
ICSI-induced decrease in number of trophectoderm cells
in female blastocysts may account for preferential female
mortality at early post-implantation stages and thereby
variations in sex ratios at birth in ART cycles. In particu-
lar, in IVF cycles the early developmental disadvantage
of females would be surpassed by the higher mortality
rates of males later in pregnancy resulting in lower sex
ratios at birth than at implantation. In contrast, in ICSI
cycles early female mortality would be comparable to
later male mortality affording similar sex ratios at birth
and implantation. Blastocyst transfer in both IVF and
ICSI cycles would be associated with higher post-
implantation female mortality than cleavage-stage trans-
fer. Consequently, sex ratios at birth would be closer to
sex ratios at implantation after blastocyst transfer than
after cleavage-stage transfer.
The hypothesis of precocious XCI may be extended to
natural cycles to explain, at least in part, some biases of
sex ratio at birth observed in human populations/fam-
ilies (for reviews, see James [65,66]). In particular, distur-
bances of XCI may be induced by biological (e.g., gametes
from reproductive-old women/men and pre- or post-
ovulation/ejaculation aged gametes) or environmental (e.g.,
maternal exposure to nutritional deficits/excesses, phys-
ical/psychological/social stresses, medications, social drugs,
radiations, environmental pollutants and chemotherapy
agents) factors. Certainly, this is a research area that needs
further attention.
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